The DOI matches its Crossref record; 393 of the 393 references it cites were found in a registry or an index.
Molecular Genetics of Acute Lymphoblastic Leukemia
Abstract
From its beginnings two decades ago with the analysis of chromosomal translocation breakpoints, research into the molecular pathogenesis of acute lymphoblastic leukemia (ALL) has now progressed to the large-scale resequencing of candidate oncogenes and tumor suppressor genes in the genomes of ALL cases blocked at various developmental stages within the B- and T-cell lineages. In this review, we summarize the findings of these investigations and highlight how this information is being integrated into multistep mutagenesis cascades that impact specific signal transduction pathways and synergistically lead to leukemic transformation. Because of these advances, fueled by improved technology for mutational analysis and the development of small-molecule drugs and monoclonal antibodies, the future is bright for a new generation of targeted therapies. Best illustrated by the successful introduction of imatinib mesylate, these new treatments will interfere with disordered molecular pathways specific for the leukemic cells, and thus should exhibit much less toxicity and fewer long-term adverse effects than currently available therapeutic modalities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–393 of 393
Sawyers, C. L., McLaughlin, J., & Witte, O. N. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.307 · Cited by 253
Meis Proteins are Major In Vivo DNA Binding Partners for Wild-Type but Not Chimeric Pbx Proteins
Chang, C.-P., Jacobs, Y., Nakamura, T., Jenkins, N. A., Copeland, N. G., & Cleary, M. L. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.10.5679 · Cited by 253
Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia
Look, A., Roberson, P., Williams, D., Rivera, G., Bowman, W., Pui, C., Ochs, J., Abromowitch, M., Kalwinsky, D., & Dahl, G. (1985) · Blood · doi:10.1182/blood.v65.5.1079.1079 · Cited by 251
Self-citationStam, K., Heisterkamp, N., Grosveld, G., de Klein, A., Verma, R. S., Coleman, M., Dosik, H., & Groffen, J. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512053132301 · Cited by 251
HOX11, a homeobox-containing T-cell oncogene on human chromosome 10q24.
Kennedy, M. A., Gonzalez-Sarmiento, R., Kees, U. R., Lampert, F., Dear, N., Boehm, T., & Rabbitts, T. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.8900 · Cited by 250
Drolet, D. W., Scully, K. M., Simmons, D. M., Wegner, M., Chu, K. T., Swanson, L. W., & Rosenfeld, M. G. (1991) · Genes & Development · doi:10.1101/gad.5.10.1739 · Cited by 246
FLT3 mutations in childhood acute lymphoblastic leukemia
Armstrong, S. A., Mabon, M. E., Silverman, L. B., Li, A., Gribben, J. G., Fox, E. A., Sallan, S. E., & Korsmeyer, S. J. (2004) · Blood · doi:10.1182/blood-2003-07-2441 · Cited by 246
Self-citationHunger, S. P., Ohyashiki, K., Toyama, K., & Cleary, M. L. (1992) · Genes & Development · doi:10.1101/gad.6.9.1608 · Cited by 239
Peifer, M., & Wieschaus, E. (1990) · Genes & Development · doi:10.1101/gad.4.7.1209 · Cited by 239
Association of SET domain and myotubularin-related proteins modulates growth control
Cui, X., Vivo, I. D., Slany, R., Miyamoto, A., Firestein, R., & Cleary, M. L. (1998) · Nature Genetics · doi:10.1038/ng0498-331 · Cited by 238
High Incidence of T-Cell Tumors in E2A-Null Mice and E2A/Id1 Double-Knockout Mice
Yan, W., Young, A. Z., Soares, V. C., Kelley, R., Benezra, R., & Zhuang, Y. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7317 · Cited by 237
Jones, R. M., Branda, J., Johnston, K. A., Polymenis, M., Gadd, M., Rustgi, A., Callanan, L., & Schmidt, E. V. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4754 · Cited by 237
Williams, D., Tsiatis, A. A., Brodeur, G. M., Look, A. T., Melvin, S., Bowman, W. P., Kalwinsky, D., Rivera, G. K., & Dahl, G. V. H. (1982) · Blood · doi:10.1182/blood.v60.4.864.864 · Cited by 236
Self-citationJones, R. S., & Gelbart, W. M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6357 · Cited by 236
Trueworthy, R., Shuster, J., Look, T., Crist, W., Borowitz, M., Carroll, A., Frankel, L., Harris, M., Wagner, H., & Haggard, M. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.4.606 · Cited by 236
Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia.
Wadman, I., Li, J., Bash, R. O., Forster, A., Osada, H., Rabbitts, T. H., & Baer, R. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06809.x · Cited by 234
Hsieh, J. J.-D., Ernst, P., Erdjument-Bromage, H., Tempst, P., & Korsmeyer, S. J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.186-194.2003 · Cited by 234
Tumor suppressor genes in normal and malignant hematopoiesis
Krug, U., Ganser, A., & Koeffler, H. P. (2002) · Oncogene · doi:10.1038/sj.onc.1205322 · Cited by 231
Sanchez-Irizarry, C., Carpenter, A. C., Weng, A. P., Pear, W. S., Aster, J. C., & Blacklow, S. C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9265-9273.2004 · Cited by 230
Kamps, M. P., Look, A. T., & Baltimore, D. (1991) · Genes & Development · doi:10.1101/gad.5.3.358 · Cited by 230
Self-citationAcute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product.
Domer, P. H., Fakharzadeh, S. S., Chen, C. S., Jockel, J., Johansen, L., Silverman, G. A., Kersey, J. H., & Korsmeyer, S. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7884 · Cited by 226
Crist, W., Carroll, A., Shuster, J., Jackson, J., Head, D., Borowitz, M., Behm, F., Link, M., Steuber, P., & Ragab, A. (1990) · Blood · doi:10.1182/blood.v76.3.489.489 · Cited by 225
Larson, R. C., Lavenir, I., Larson, T. A., Baer, R., Warren, A. J., Wadman, I., Nottage, K., & Rabbitts, T. H. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00439.x · Cited by 221
Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells.
Zakut-Houri, R., Bienz-Tadmor, B., Givol, D., & Oren, M. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03768.x · Cited by 218
Cortez, D., Reuther, G., & Pendergast, A. M. (1997) · Oncogene · doi:10.1038/sj.onc.1201400 · Cited by 216
Biology and treatment of infant leukemias.
Pui, C., Kane, J. R., & Crist, W. (1995) · PubMed · Cited by 213
Findley, H. W., Gu, L., Yeager, A. M., & Zhou, M. (1997) · Blood · doi:10.1182/blood.v89.8.2986 · Cited by 213
Valge-Archer, V. E., Osada, H., Warren, A. J., Forster, A., Li, J., Baer, R., & Rabbitts, T. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8617 · Cited by 212
Brown, P., Levis, M., Shurtleff, S., Campana, D., Downing, J., & Small, D. (2005) · Blood · doi:10.1182/blood-2004-06-2498 · Cited by 212
Inukai, T., Inoue, A., Kurosawa, H., Goi, K., Shinjyo, T., Ozawa, K., Mao, M., Inaba, T., & Look, A. T. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80336-6 · Cited by 211
Self-citationActivation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants.
Varticovski, L., Daley, G. Q., Jackson, P., Baltimore, D., & Cantley, L. C. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.2.1107 · Cited by 210
Grandori, C., Mac, J., Siëbelt, F., Ayer, D. E., & Eisenman, R. N. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00808.x · Cited by 208
An 8-kilobase abl RNA transcript in chronic myelogenous leukemia.
Gale, R. P., & Canaani, E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.18.5648 · Cited by 208
Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia
Coustan-Smith, E., Kitanaka, A., Pui, C., McNinch, L., Evans, W., Raimondi, S., Behm, F., Arico, M., & Campana, D. (1996) · Blood · doi:10.1182/blood.v87.3.1140.bloodjournal8731140 · Cited by 208
Jousset, C., Carron, C., Boureux, A., Quang, C. T., Oury, C., Dusanter‐Fourt, I., Charon, M., Levin, J., Bernard, O., & Ghysdael, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.1.69 · Cited by 207
Xia, Y., Brown, L., Yang, C. Y., Tsan, J. T., Siciliano, M. J., Espinosa, R., Le Beau, M. M., & Baer, R. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11416 · Cited by 207
Altered Transcription of the c- abl Oncogene in K-562 and Other Chronic Myelogenous Leukemia Cells
Collins, S. J., Kubonishi, I., Miyoshi, I., & Groudine, M. T. (1984) · Science · doi:10.1126/science.6587568 · Cited by 206
Inoue, A., Seidel, M. G., Wu, W., Kamizono, S., Ferrando, A. A., Bronson, R. T., Iwasaki, H., Akashi, K., Morimoto, A., Hitzler, J. K., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00155-1 · Cited by 204
Self-citationErikson, J., Nishikura, K., ar-Rushdi, A., Finan, J., Emanuel, B., Lenoir, G., Nowell, P. C., & Croce, C. M. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.24.7581 · Cited by 204
Lavau, C. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4655 · Cited by 203
Croce, C. M., Thierfelder, W., Erikson, J., Nishikura, K., Finan, J., Lenoir, G. M., & Nowell, P. C. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.22.6922 · Cited by 202
Grosveld, G., Verwoerd, T., van Agthoven, T., de Klein, A., Ramachandran, K. L., Heisterkamp, N., Stam, K., & Groffen, J. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.2.607 · Cited by 202
Harris, M., Shuster, J., Carroll, A., Look, A., Borowitz, M., Crist, W., Nitschke, R., Pullen, J., Steuber, C., & Land, V. (1992) · Blood · doi:10.1182/blood.v79.12.3316.3316 · Cited by 201
Self-citation11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia.
Pui, C. H., Behm, F. G., Downing, J. R., Hancock, M. L., Shurtleff, S. A., Ribeiro, R. C., Head, D. R., Mahmoud, H. H., Sandlund, J. T., & Furman, W. L. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.5.909 · Cited by 201
Oncogenic conversion of transcription factors by chromosomal translocations
Cleary, M. L. (1991) · Cell · doi:10.1016/0092-8674(91)90105-8 · Cited by 200
Rubnitz, J. E., Downing, J. R., Pui, C. H., Shurtleff, S. A., Raimondi, S. C., Evans, W. E., Head, D. R., Crist, W. M., Rivera, G. K., Hancock, M. L., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.1150 · Cited by 197
A Common Mechanism of Chromosomal Translocation in T- and B-Cell Neoplasia
Finger, L. R., Harvey, R. C., Moore, R. C. A., Showe, L. C., & Croce, C. M. (1986) · Science · doi:10.1126/science.3490692 · Cited by 197
Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias
So, C. W., Lin, M., Ayton, P. M., Chen, E. H., & Cleary, M. L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00188-0 · Cited by 196
Deregulation of c- myc by Translocation of the α-Locus of the T-Cell Receptor in T-Cell Leukemias
Erikson, J., Finger, L., Sun, L., ar-Rushdi, A., Nishikura, K., Minowada, J., Finan, J., Emanuel, B. S., Nowell, P. C., & Croce, C. M. (1986) · Science · doi:10.1126/science.3486470 · Cited by 195
Mazo, A. M., Huang, D. H., Mozer, B. A., & Dawid, I. B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2112 · Cited by 194
11q23 rearrangements in acute leukemia.
Rubnitz, J. E., Behm, F. G., & Downing, J. R. (1996) · PubMed · Cited by 192
Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia
Okuda, T., Shurtleff, S., Valentine, M., Raimondi, S., Head, D., Behm, F., Curcio- Brint, A., Liu, Q., Pui, C., & Sherr, C. (1995) · Blood · doi:10.1182/blood.v85.9.2321.bloodjournal8592321 · Cited by 192
The SCL Gene: From Case Report to Critical Hematopoietic Regulator
Begley, C. G., & Green, A. R. (1999) · Blood · doi:10.1182/blood.v93.9.2760 · Cited by 191
Dedera, D. A., Waller, E. K., LeBrun, D. P., Sen-Majumdar, A., Stevens, M. E., Barsh, G. S., & Cleary, M. L. (1993) · Cell · doi:10.1016/0092-8674(93)90463-z · Cited by 189
Dube, I., Kamel-Reid, S., Yuan, C., Lu, M., Wu, X., Corpus, G., Raimondi, S., Crist, W., Carroll, A., & Minowada, J. (1991) · Blood · doi:10.1182/blood.v78.11.2996.2996 · Cited by 187
Raimondi, S. C., Behm, F. G., Roberson, P. K., Williams, D. L., Pui, C. H., Crist, W. M., Look, A. T., & Rivera, G. K. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.8.1380 · Cited by 184
Self-citationNiki, M., Okada, H., Takano, H., Kuno, J., Tani, K., Hibino, H., Asano, S., Ito, Y., Satake, M., & Noda, T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5697 · Cited by 182
Rubnitz, J., Link, M., Shuster, J., Carroll, A., Hakami, N., Frankel, L., Pullen, D., & Cleary, M. (1994) · Blood · doi:10.1182/blood.v84.2.570.570 · Cited by 179
An Mll-Dependent Hox Program Drives Hematopoietic Progenitor Expansion
Ernst, P., Mabon, M., Davidson, A. J., Zon, L. I., & Korsmeyer, S. J. (2004) · Current Biology · doi:10.1016/j.cub.2004.11.012 · Cited by 179
Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood
Wada, M., Bartram, C., Nakamura, H., Hachiya, M., Chen, D., Borenstein, J., Miller, C., Ludwig, L., Hansen-Hagge, T., & Ludwig, W. (1993) · Blood · doi:10.1182/blood.v82.10.3163.3163 · Cited by 178
Coordinate regulation of downstream genes by extradenticle and the homeotic selector proteins.
Rauskolb, C., & Wieschaus, E. F. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06663.x · Cited by 173
Ribeiro, R., Abromowitch, M., Raimondi, S., Murphy, S., Behm, F., & Williams, D. (1987) · Blood · doi:10.1182/blood.v70.4.948.948 · Cited by 173
The CML-Specific P210 bcr / abl Protein, Unlike v- abl , Does Not Transform NIH/3T3 Fibroblasts
Daley, G. Q., McLaughlin, J., Witte, O. N., & Baltimore, D. (1987) · Science · doi:10.1126/science.2440107 · Cited by 172
Miltenberger, R. J., Sukow, K. A., & Farnham, P. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2527 · Cited by 172
Rnx deficiency results in congenital central hypoventilation
Shirasawa, S., Arata, A., Onimaru, H., Roth, K. A., Brown, G. A. J., Horning, S. E., Arata, S., Okumura, K., Sasazuki, T., & Korsmeyer, S. J. (2000) · Nature Genetics · doi:10.1038/73516 · Cited by 172
c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets
Bush, A., Mateyak, M., Dugan, K., Obaya, A., Adachi, S., Sedivy, J., & Cole, M. (1998) · Genes & Development · doi:10.1101/gad.12.24.3797 · Cited by 172
Dimerization of MLL fusion proteins immortalizes hematopoietic cells
Martin, M. E., Milne, T. A., Bloyer, S., Galoian, K., Shen, W., Gibbs, D., Brock, H. W., Slany, R., & Hess, J. L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00214-9 · Cited by 168
The Hox11 gene is essential for cell survival during spleen development
Dear, T. N., Colledge, W. H., Carlton, M. B. L., Lavenir, I., Larson, T., Smith, A. J. H., Warren, A. J., Evans, M. J., Sofroniew, M. V., & Rabbitts, T. H. (1995) · Development · doi:10.1242/dev.121.9.2909 · Cited by 168
Myc versus USF: Discrimination at the cad Gene Is Determined by Core Promoter Elements
Boyd, K. E., & Farnham, P. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2529 · Cited by 167
Müller, D., Bouchard, C., Rudolph, B., Steiner, P., Stuckmann, I., Saffrich, R., Ansorge, W., Huttner, W., & Eilers, M. (1997) · Oncogene · doi:10.1038/sj.onc.1201440 · Cited by 167
Mutations in the Wilms' tumor gene WT1 in leukemias
King-Underwood, L., Renshaw, J., & Pritchard-Jones, K. (1996) · Blood · doi:10.1182/blood.v87.6.2171.bloodjournal8762171 · Cited by 167
HOX and Non‐HOX Homeobox Genes in Leukemic Hematopoiesis
Owens, B. M., & Hawley, R. G. (2002) · STEM CELLS · doi:10.1634/stemcells.20-5-364 · Cited by 166
Silverman, L., Declerck, L., Gelber, R., Dalton, V., Asselin, B., Barr, R., Clavell, L., Hurwitz, C., Moghrabi, A., Samson, Y., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401980 · Cited by 166
Hsu, H. L., Cheng, J. T., Chen, Q., & Baer, R. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.6.3037 · Cited by 166
CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCR lineage
Asnafi, V. (2003) · Blood · doi:10.1182/blood-2002-09-2913 · Cited by 165
Bash, R., Hall, S., Timmons, C., Crist, W., Amylon, M., Smith, R., & Baer, R. (1995) · Blood · doi:10.1182/blood.v86.2.666.bloodjournal862666 · Cited by 162
Yokoyama, A., Kitabayashi, I., Ayton, P. M., Cleary, M. L., & Ohki, M. (2002) · Blood · doi:10.1182/blood-2002-04-1015 · Cited by 162
Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases.
Wisniewski, D. J., Lambek, C. L., Liu, C., Strife, A., Veach, D. R., Nagar, B., Young, M. A., Schindler, T. H., Bornmann, W. G., Bertino, J. R., et al. (2002) · PubMed · Cited by 161
Kamps, M. P., & Baltimore, D. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.351-357.1993 · Cited by 157
Transcriptional regulator of programmed cell death encoded by Caenorhabditis elegans gene ces-2
Metzstein, M. M., Hengartner, M. O., Tsung, N., Ellis, R. E., & Horvitz, H. R. (1996) · Nature · doi:10.1038/382545a0 · Cited by 157
Takeuchi, S., Bartram, C., Seriu, T., Cw, M., Tobler, A., Janssen, J. W. G., Reiter, A., Ludwig, W., Zimmermann, M., & Schwaller, J. (1995) · Blood · doi:10.1182/blood.v86.2.755.bloodjournal862755 · Cited by 157
Ferrando, A. A., Neuberg, D. S., Dodge, R. K., Paietta, E. M., Larson, R. A., Wiernik, P. H., Rowe, J. M., Caligiuri, M. A., Bloomfield, C. D., & Look, A. T. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15542-6 · Cited by 155
Self-citationSkórski, T. (2002) · Oncogene · doi:10.1038/sj.onc.1206087 · Cited by 154
ALTERED TRANSCRIPTION OF AN ONCOGENE IN CHRONIC MYELOID LEUKAEMIA
Canaani, E., Steiner-Salz, D., Aghai, E., Gale, R. P., Berrebi, A., & Januszewicz, E. H. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90997-8 · Cited by 153
McWhirter, J. R., Neuteboom, S., Wancewicz, E. V., Monia, B. P., Downing, J. R., & Murre, C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11464 · Cited by 153
Aplan, P. D., Jones, C. A., Chervinsky, D. S., Zhao, X. F., Ellsworth, M., Wu, C., McGuire, E. A., & Gross, K. W. (1997) · The EMBO Journal · doi:10.1093/emboj/16.9.2408 · Cited by 151
Ferrando, A. A., & Look, A. T. (2000) · Seminars in Hematology · doi:10.1016/s0037-1963(00)90018-0 · Cited by 151
Self-citationMeeker, T. C., Hardy, D. A., Willman, C. L., Hogan, T. F., & Abrams, J. S. (1990) · Blood · doi:10.1182/blood.v76.2.285.285 · Cited by 150
Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice.
Gishizky, M. L., Johnson-White, J., & Witte, O. N. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3755 · Cited by 148
Lu, M., Gong, Z. Y., Shen, W. F., & Ho, A. D. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07840.x · Cited by 147
Williams, D., Harber, J. R., Murphy, S., Look, A. T., Kalwinsky, D., Rivera, G. K., Melvin, S., Stass, S. A., & Dahl, G. V. H. (1986) · Blood · doi:10.1182/blood.v68.1.205.205 · Cited by 147
Self-citationNew mechanisms of AML1 gene alteration in hematological malignancies
Roumier, C., Fenaux, P., Lafage‐Pochitaloff, M., Imbert, M., Éclache, V., & Preudhomme, C. (2003) · Leukemia · doi:10.1038/sj.leu.2402766 · Cited by 146
Heerema, N., Arthur, D., Sather, H. N., Albo, V. C., Feusner, J. H., Lange, B., Steinherz, P., Zeltzer, P. M., Hammond, D., & Reaman, G. (1994) · Blood · doi:10.1182/blood.v83.8.2274.2274 · Cited by 145
The role of E2A-PBX1 in leukemogenesis
Aspland, S. E., Bendall, H. H., & Murre, C. (2001) · Oncogene · doi:10.1038/sj.onc.1204592 · Cited by 141
Aplan, P., Lombardi, D., Reaman, G., Sather, H. N., Hammond, G. D., & Kirsch, I. R. (1992) · Blood · doi:10.1182/blood.v79.5.1327.1327 · Cited by 140
p16 gene homozygous deletions in acute lymphoblastic leukemia
Quesnel, B., Preudhomme, C., Philippe, N., Vanrumbeke, M., Dervite, I., Laï, J., Bauters, F., Wattel, E., & Fenaux, P. (1995) · Blood · doi:10.1182/blood.v85.3.657.bloodjournal853657 · Cited by 139
Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia
Kawamura, M., Ohnishi, H., Guo, S.-X., Sheng, X., Minegishi, M., Hanada, R., Horibe, K., Hongo, T., Kaneko, Y., Bessho, F., et al. (1999) · Leukemia Research · doi:10.1016/s0145-2126(98)00146-5 · Cited by 139
The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10
DiMartino, J. F., Ayton, P. M., Chen, E. H., et al. (2002) · Blood · doi:10.1182/blood.v99.10.3780 · Cited by 137
Tumorigenesis in mice with a fusion of the leukaemia oncogene Mll and the bacterial lacZ gene
Dobson, C., Warren, A. J., Pannell, R., Forster, A. M., & Rabbitts, T. H. (2000) · The EMBO Journal · doi:10.1093/emboj/19.5.843 · Cited by 137
Guidez, F., Petrie, K. R., Ford, A. M., Lu, H., Bennett, C. A., MacGregor, A., Hannemann, J., Ito, Y., Ghysdael, J., Greaves, M. F., et al. (2000) · Blood · doi:10.1182/blood.v96.7.2557 · Cited by 137
Ma, Q., Alder, H., Nelson, K. K., Chatterjee, D., Gu, Y., Nakamura, T., Canaani, E., Croce, C. M., Siracusa, L. D., & Buchberg, A. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6350 · Cited by 135
Overexpression of the Helix–Loop–Helix protein Id2 blocks T cell development at multiple stages
Morrow, M. A., Mayer, E. W., Perez, C. A., Adlam, M., & Siu, G. (1999) · Molecular Immunology · doi:10.1016/s0161-5890(99)00071-1 · Cited by 135
Positive and Negative Regulation of V(D)J Recombination by the E2A Proteins
Bain, G., Romanow, W. J., Albers, K., Havran, W. L., & Murre, C. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.289 · Cited by 135
Fletcher, J., Lynch, E., Dalton, V. K., Donnelly, M., Tantravahi, R. V., & Sallan, S. E. (1991) · Blood · doi:10.1182/blood.v77.3.435.435 · Cited by 134
Bcl2 inhibits apoptosis associated with terminal differentiation of HL- 60 myeloid leukemia cells
Naumovski, L., & Cleary, M. L. (1994) · Blood · doi:10.1182/blood.v83.8.2261.2261 · Cited by 134
Forster, A. M., Pannell, R., Drynan, L. F., McCormack, M. P., Collins, E. C., Daser, A., & Rabbitts, T. H. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00106-5 · Cited by 134
Biology and treatment of acute lymphoblastic leukemia
Pui, C., & Crist, W. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83125-7 · Cited by 134
Aronheim, A., Shiran, R., Rosen, A., & Walker, M. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8063 · Cited by 134
Ferrando, A. A., Herblot, S., Palomero, T., Hansen, M., Hoang, T., Fox, E. A., & Look, A. T. (2003) · Blood · doi:10.1182/blood-2003-07-2577 · Cited by 133
Self-citationp53 dependent growth suppression by the c-Abl nuclear tyrosine kinase.
Goga, A., Liu, X., Hambuch, T. M., Senechal, K., Major, E., Berk, A. J., Witte, O. N., & Sawyers, C. L. (1995) · PubMed · Cited by 133
Breit, T. M., Mol, E., Wolvers-Tettero, I. L. M., Ludwig, W. D., van Wering, E. R., & van Dongen, J. J. M. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.4.965 · Cited by 132
The C. elegans Cell Death Specification Gene ces-1 Encodes a Snail Family Zinc Finger Protein
Metzstein, M. M., & Horvitz, H. R. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80333-0 · Cited by 128
Dear, T. N., Sánchez-Garcı́a, I., & Rabbitts, T. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4431 · Cited by 128
Hangaishi, A., Ogawa, S., Imamura, N., Miyawaki, S., Miura, Y., Uike, N., Shimazaki, C., Emi, N., Takeyama, K., Hirosawa, S., et al. (1996) · Blood · doi:10.1182/blood.v87.12.4949.bloodjournal87124949 · Cited by 127
Privitera, E., Kamps, M. P., Hayashi, Y., Inaba, T., Shapiro, L., Raimondi, S., Behm, F. G., Hendershot, L. M., Carroll, A. J., & Baltimore, D. (1992) · Blood · doi:10.1182/blood.v79.7.1781.1781 · Cited by 126
Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia
Diccianni, M. B., Yu, A. L.-T., Hsiao, M., Mukherjee, S., Shao, L.-E., & Yu, A. L.-T. (1994) · Blood · doi:10.1182/blood.v84.9.3105.3105 · Cited by 123
A novel alteration in the structure of an activated c-myc gene in a variant t(2;8) burkitt lymphoma
Taub, R. A., Kelly, K., Battey, J., et al. (1984) · Cell · doi:10.1016/0092-8674(84)90381-7 · Cited by 122
Rubnitz, J. E., Morrissey, J. J., Savage, P. A., & Cleary, M. L. (1994) · Blood · doi:10.1182/blood.v84.6.1747.1747 · Cited by 122
Reversal of apoptosis by the leukaemia-associated E2A–HLF chimaeric transcription factor
Inaba, T., Inukai, T., Yoshihara, T., Seyschab, H., Ashmun, R. A., Canman, C. E., Laken, S. J., Kastan, M. B., & Look, A. T. (1996) · Nature · doi:10.1038/382541a0 · Cited by 121
Self-citationMcGuire, E. A., Rintoul, C. E., Sclar, G. M., & Korsmeyer, S. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.9.4186 · Cited by 119
Huron, D. R., Gorre, M. E., Kraker, A. J., Sawyers, C. L., Rosen, N. X., & Moasser, M. M. (2003) · PubMed · Cited by 118
Childhood Acute Lymphoblastic Leukemia With the MLL-ENL Fusion and t(11;19)(q23;p13.3) Translocation
Rubnitz, J. E., Camitta, B. M., Mahmoud, H. H., Raimondi, S. C., Carroll, A. J., Borowitz, M. J., Shuster, J. J., Link, M. P., Pullen, D. J., Downing, J. R., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.191 · Cited by 116
Baer, R. J. (1993) · PubMed · Cited by 116
Cytogenetics of childhood acute nonlymphocytic leukemia
Raimondi, S. C., Kalwinsky, D. K., Hayashi, Y., Behm, F. G., Mirro, J., & Williams, D. L. (1989) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(89)90141-6 · Cited by 114
von Bubnoff, N. C. C., Peschel, C., & Duyster, J. (2003) · Leukemia · doi:10.1038/sj.leu.2402889 · Cited by 114
The role of TEL fusion genes in pediatric leukemias
Rubnitz, J. E., Pui, C., & Downing, J. R. (1999) · Leukemia · doi:10.1038/sj.leu.2401258 · Cited by 114
Molecular mechanisms of resistance to STI571 in chronic myeloid leukemia
Gorre, M. E., & Sawyers, C. L. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200207000-00007 · Cited by 113
A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias
Morrissey, J. J., Tkachuk, D., Milatovich, A., Francke, U., Link, M., & Cleary, M. L. (1993) · Blood · doi:10.1182/blood.v81.5.1124.1124 · Cited by 112
Fizzotti, M., Cimino, G. G., Pisegna, S., Alimena, G., Quartarone, C., Mandelli, F., Pelicci, P. G., & Coco, F. L. (1995) · Blood · doi:10.1182/blood.v85.10.2685.bloodjournal85102685 · Cited by 110
Greenberg, J. M., Boehm, T. L. J., Sofroniew, M. V., Keynes, R. J., Barton, S. C., Norris, M. L., Surani, M. A., Spillantini, M. G., & Rabbitts, T. H. (1990) · Nature · doi:10.1038/344158a0 · Cited by 107
Allen, J. D., Lints, T., Jenkins, N. A., Copeland, N. G., Strasser, A., Harvey, R. P., & Adams, J. M. (1991) · Genes & Development · doi:10.1101/gad.5.4.509 · Cited by 107
Notch and the Amyloid Precursor Protein Are Cleaved by Similar γ-Secretase(s)
Kimberly, W. T., Esler, W. P., Ye, W., Ostaszewski, B. L., Gao, J., Diehl, T. S., Selkoe, D. J., & Wolfe, M. S. (2002) · Biochemistry · doi:10.1021/bi026888g · Cited by 107
Rowley, J. D. (1990) · PubMed · Cited by 107
Cayuela, J., Madani, A., Sanhes, L., Stern, M., & Sigaux, F. (1996) · Blood · doi:10.1182/blood.v87.6.2180.bloodjournal8762180 · Cited by 106
New recurring chromosomal translocations in childhood acute lymphoblastic leukemia
Raimondi, S., Privitera, E., Williams, D., Look, A. T., Behm, F., Rivera, G. K., Crist, W., & Pui, C. (1991) · Blood · doi:10.1182/blood.v77.9.2016.2016 · Cited by 105
Self-citationDiMartino, J. F., Miller, T., Ayton, P. M., Landewe, T., Hess, J. L., Cleary, M. L., & Shilatifard, A. (2000) · Blood · doi:10.1182/blood.v96.12.3887 · Cited by 105
Falvey, E., Fleury-Olela, F., & Schibler, U. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00105.x · Cited by 105
Maloney, K., Shuster, J. J., Murphy, S. B., Pullen, J., & Camitta, B. M. (2000) · Leukemia · doi:10.1038/sj.leu.2401965 · Cited by 105
ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemia
Cavé, H., Cacheux, V., Raynaud, S., Brunie, G., Bakkus, M. H. C., Cochaux, P., Preudhomme, C., Laï, J., VILMER, E., & Grandchamp, B. (1997) · Leukemia · doi:10.1038/sj.leu.2400798 · Cited by 104
Fu, X., & Kamps, M. P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1503 · Cited by 104
Kohlmann, A., Schoch, C., Schnittger, S., Dugas, M., Hiddemann, W., Kern, W., & Haferlach, T. (2003) · Leukemia · doi:10.1038/sj.leu.2403167 · Cited by 103
Chervinsky, D. S., Zhao, X. F., Lam, D., Ellsworth, M., Gross, K. W., & Aplan, P. D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.5025 · Cited by 103
Positive and negative transcriptional control by the TAL1 helix-loop-helix protein.
Hsu, H. L., Wadman, I., Tsan, J. T., & Baer, R. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.5947 · Cited by 98
Rubnitz, J. E., Behm, F., Pui, C.-H., Evans, W., Relling, M. V., Raimondi, S., Harrison, P., Sandlund, J. T., Ribeiro, R., Grosveld, G. C., et al. (1997) · Leukemia · doi:10.1038/sj.leu.2400779 · Cited by 97
T cell tumours of disparate phenotype in mice transgenic for Rbtn-2.
Larson, R. C., Fisch, P., Larson, T., Lavenir, I., Langford, T., King, G., & Rabbitts, T. H. (1994) · PubMed · Cited by 95
Larson, R. C., Osada, H., Ta, L., Lavenir, I., & Rabbitts, T. H. (1995) · PubMed · Cited by 94
Feldman, B. J., Hampton, T., & Cleary, M. L. (2000) · Blood · doi:10.1182/blood.v96.5.1906 · Cited by 93
Wang, J., Jani-Sait, S., Escalon, E., Carroll, A. J., de Jong, P. J., Kirsch, I. R., & Aplan, P. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3497 · Cited by 93
Mutations of the p53 and ras genes in childhood t(1;19)-acute lymphoblastic leukemia
Kawamura, M., Kikuchi, A., Kobayashi, S., et al. (1995) · Blood · doi:10.1182/blood.v85.9.2546.bloodjournal8592546 · Cited by 86
Berger, R., Dastugue, N., Busson, M., van den Akker, J., Pérot, C., Ballerini, P. F., Hagemeijer, A., Michaux, L., Charrin, C., Pagès, M.-P., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403061 · Cited by 86
Kelliher, M. A., Knott, A., McLaughlin, J., Witte, O. N., & Rosenberg, N. E. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.9.4710 · Cited by 86
Cancer risks from germline p53 mutations.
Frébourg, T., & Friend, S. H. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116034 · Cited by 82
Hoemann, C. D., Beaulieu, N., Girard, L., Rebaï, N., & Jolicoeur, P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.3831-3842.2000 · Cited by 82
Hsiao, M., Yu, A. L.-T., Yeargin, J., Ku, D., & Haas, M. (1994) · Blood · doi:10.1182/blood.v83.10.2922.2922 · Cited by 82
Rubnitz, J. E., Shuster, J. J., Land, V. J., Link, M. P., Pullen, D. J., Camitta, B. M., Pui, C., Downing, J. R., & Behm, F. G. (1997) · Blood · doi:10.1182/blood.v89.4.1143 · Cited by 81
Downing, J. R., Head, D., Raimondi, S., et al. (1994) · Blood · doi:10.1182/blood.v83.2.330.330 · Cited by 81
The Tal1 Oncoprotein Inhibits E47-mediated Transcription
Park, S. T., & Sun, X.-H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.7030 · Cited by 77
Marks, D. I., Kurz, B. W., Link, M., Ng, E., Shuster, J. J., Lauer, S. J., Brodsky, I., & Haines, D. S. (1996) · Blood · doi:10.1182/blood.v87.3.1155.bloodjournal8731155 · Cited by 77
p16INK4A and p15INK4B gene deletions in primary leukemias
Haidar, M., Cao, X., Manshouri, T., Chan, L. L., Glassman, A. B., Kantarjian, H., Keating, M. J., Beran, M., & Albitar, M. X. (1995) · Blood · doi:10.1182/blood.v86.1.311.bloodjournal861311 · Cited by 76
Neale, G., Rehg, J., & Goorha, R. (1995) · Blood · doi:10.1182/blood.v86.8.3060.3060 · Cited by 74
Liang, D.-C., Chou, T.-B., Chen, J.-S., Shurtleff, S. A., Rubnitz, J. E., Downing, J. R., Pui, C., & Shih, L. (1996) · PubMed · Cited by 74
Two MAD tails: what the recent knockouts of Mad1 and Mxi1 tell us about the MYC/MAX/MAD network
Foley, K. P., & Eisenman, R. N. (1999) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(99)00012-8 · Cited by 72
Heyman, M. M., Rasool, O., Brandter, L., Liu, Y., Grandér, D., Söderhäll, S., Gustavsson, G., & Einhorn, S. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1512 · Cited by 71
Schuldiner, O., Eden, A., Ben‐Yosef, T., Yanuka, O., Simchen, G., & Benvenisty, N. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7143 · Cited by 70
Inaba, T., Shapiro, L. H., Funabiki, T., Sinclair, A., Jones, B. G., Ashmun, R. A., & Look, A. T. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.3403 · Cited by 68
Self-citationMiyamoto, A., Cui, X., Naumovski, L., & Cleary, M. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2394 · Cited by 67
Lü, Q., & Kamps, M. P. (1997) · Oncogene · doi:10.1038/sj.onc.1200799 · Cited by 67
Narita, M., Shimizu, K., Hayashi, Y., Taki, T., Taniwaki, M., Hosoda, F., Kobayashi, H., Nakamura, H., Sadamori, N., Ohnishi, H., et al. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01433.x · Cited by 66
Two types of genomic rearrangements create alternative E2A-HLF fusion proteins in t(17;19)-ALL
Hunger, S. P., Devaraj, P. E., Foroni, L., Secker‐Walker, L. M., & Cleary, M. L. (1994) · Blood · doi:10.1182/blood.v83.10.2970.2970 · Cited by 66
The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice
O’Neil, J., Billa, M., Oikemus, S., & Kelliher, M. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204519 · Cited by 65
Hunger, S. P., Brown, R., & Cleary, M. L. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.9.5986 · Cited by 61
p15ink4B and p16ink4 gene inactivation in acute lymphocytic leukemia
Rasool, O., Heyman, M. M., Brandter, L., Liu, Y., Grandér, D., Söderhäll, S., & Einhorn, S. (1995) · Blood · doi:10.1182/blood.v85.12.3431.bloodjournal85123431 · Cited by 57
Studying the pathogenesis of BCR–ABL+ leukemia in mice
Etten, R. A. V. (2002) · Oncogene · doi:10.1038/sj.onc.1206091 · Cited by 56
Variable breakpoints on the Philadelphia chromosome in chronic myelogenous leukemia
Leibowitz, D. S., Schaefer-Rego, K. E., Popenoe, D., Mears, J., & Bank, A. (1985) · Blood · doi:10.1182/blood.v66.1.243.243 · Cited by 54
Marks, D. I., Kurz, B. W., Link, M. P., Ng, E., Shuster, J. J., Lauer, S. J., Carroll, D., Brodsky, I., & Haines, D. S. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.1158 · Cited by 51
Takeuchi, S., Seriu, T., Bartram, C., Golub, T. R., Reiter, A., Miyoshi, I., Gilliland, D. G., & Koeffler, H. (1997) · Leukemia · doi:10.1038/sj.leu.2400743 · Cited by 48
Golub, T. R., Barker, G. F., Stegmaier, K., & Gilliland, D. G. (1997) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-60479-9_5 · Cited by 47
Mnt: A Novel Max-interacting Protein and Myc Antagonist
Hurlin, P. J., Quéva, C., & Eisenman, R. N. (1997) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-60801-8_11 · Cited by 46
Mai, S., & Jalava, A. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.12.2264 · Cited by 46
WT1: a novel tumor suppressor gene inactivated in Wilms' tumor.
Haber, D. A., & Buckler, A. (1992) · PubMed · Cited by 46
Molecular genetics of acute leukaemia
Sawyers, C. L. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07535-6 · Cited by 45
Iolascon, A., Faienza, M. F., Coppola, B., Ragione, F. D., Schettini, F., & Biondi, A. (1996) · PubMed · Cited by 42
Kamps, M. P., & Wright, D. D. (1994) · PubMed · Cited by 40
Allen, J., & Adams, J. M. (1993) · Blood · doi:10.1182/blood.v81.12.3242.3242 · Cited by 38
Cell Transformation Mediated by Homodimeric E2A-HLF Transcription Factors
Inukai, T., Inaba, T., Yoshihara, T., & Look, A. T. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1417 · Cited by 36
Self-citationInvolvement of the TEL Gene in Hematologic Malignancy by Diverse Molecular Genetic Mechanisms
Golub, T. R., Barker, G. F., Stegmaier, K., & Gilliland, D. G. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-85232-9_28 · Cited by 31
Cellular Targets for Activation by c-Myc Include the DNA Metabolism Enzyme Thymidine Kinase
Pusch, O., Soucek, T., Hengstschläger-Ottnad, E., BERNASCHEK, G., & Hengstschläger, M. (1997) · DNA and Cell Biology · doi:10.1089/dna.1997.16.737 · Cited by 30
Smith, K. S., Jacobs, Y., Chang, C., & Cleary, M. L. (1997) · Oncogene · doi:10.1038/sj.onc.1201249 · Cited by 30
Nakao, M., Yokota, S., Kaneko, H., Seriu, T., Koizumi, S., Takaue, Y., Fujimoto, T., & Misawa, S. (1996) · PubMed · Cited by 17
Cancer genetics: Two tracks but one race?
Sidransky, D. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00532-8 · Cited by 16
Cited by
Vardiman, J. W., Thiele, J., Arber, D. A., Brunning, R. D., Borowitz, M. J., Porwit, A., Harris, N. L., Le Beau, M. M., Hellström-Lindberg, E., Tefferi, A., et al. (2009) · Blood · doi:10.1182/blood-2009-03-209262 · Cited by 4,424
Treatment of Acute Lymphoblastic Leukemia
Pui, C.-H., & Evans, W. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052603 · Cited by 1,976
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
Hacein-Bey-Abina, S., Garrigue, A., Wang, G. P., Soulier, J., Lim, A., Morillon, E., Clappier, E., Caccavelli, L., Delabesse, E., Beldjord, K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35700 · Cited by 1,854
Pui, C.-H., Robison, L. L., & Look, A. T. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60457-2 · Cited by 1,564
Self-citationCancer Stem Cells: Impact, Heterogeneity, and Uncertainty
Magee, J. A., Piskounova, E., & Morrison, S. J. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.003 · Cited by 1,101
Metadata
- Authors
- Armstrong, S. A., & Look, A. T.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-09-10
- Volume
- 23
- Issue
- 26
- Pages
- 6306-6315
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2102193258
- Cited by
- 362
- References
- 393
- FWCI
- 26.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.